Research graph
References from Cross national pharmacovigilance analysis of drug-induced delirium: a comparative study using the US FAERS, Japanese JADER, and canadian CVAR datasets. Local targets link to admitted publications; unresolved targets remain external evidence.
A brief review of the history of delirium as a mental disorder
10.1177/0957154x07076467 · 2007 · External reference
An approach to drug induced delirium in the elderly
10.1136/pgmj.2003.017236 · 2004 · External reference
Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis
10.1007/s00204-020-02788-1 · 2020 · External reference
The fine line between relief and risk: new insights into postoperative delirium
10.1016/j.bja.2024.10.006 · 2025 · External reference
Adverse event detection in drug development: recommendations and obligations beyond phase 3
10.2105/ajph.2007.124537 · 2008 · External reference
Clinical assessment and management of delirium in the palliative care setting
10.1007/s40265-017-0804-3 · 2017 · External reference
American Geriatrics Society 2023 updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults
10.1111/jgs.18372 · 2023 · External reference
The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity
10.1177/0091270006292126 · 2006 · External reference
Identification and management of in-hospital drug-induced delirium in older patients
10.2165/11592240-000000000-00000 · 2011 · External reference
Enhancing adverse drug reaction data quality in Canada: a high-precision pipeline for medication name standardization and enrichment
10.1371/journal.pone.0331940 · 2025 · External reference
A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database
10.1016/j.ebiom.2024.105314 · 2024 · External reference
Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit
10.1001/jama.291.14.1753 · 2004 · External reference
The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): development and statement
10.1007/s40264-024-01421-9 · External reference
The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration
10.1007/s40264-024-01423-7 · External reference
Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study
10.1001/jamainternmed.2014.7663 · 2015 · External reference
Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: an electronic health records network study
10.1177/0269881120936501 · 2020 · External reference
Delirium in elderly people
10.1016/s0140-6736(13)60688-1 · 2014 · External reference
Association between polypharmacy and the persistence of delirium: a retrospective cohort study
10.1186/s13030-020-00199-3 · 2020 · External reference
One-year health care costs associated with delirium in the elderly population
10.1001/archinternmed.2007.4 · 2008 · External reference
Does preoperative risk for delirium moderate the effects of postoperative pain and opiate use on postoperative delirium?
10.1016/j.jagp.2013.01.069 · 2013 · External reference
Strategies and tools for supporting the appropriateness of drug use in older people
10.3390/ph15080977 · 2022 · External reference
Delirium in hospitalized older adults
10.1056/nejmcp1605501 · 2017 · External reference
Drug-induced cognitive impairment: effect of cardiovascular agents
10.9740/mhc.2016.07.201 · 2016 · External reference
Polypharmacy and anticholinergic burden as risk factors for postoperative delirium in surgical medicine
10.1007/s00391-024-02388-z · 2025 · External reference
Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration
10.1177/20420986251361435 · 2025 · External reference
Predisposing and precipitating factors associated with delirium: a systematic review
10.1001/jamanetworkopen.2022.49950 · 2023 · External reference
Long-term cognitive impairment after critical illness
10.1056/nejmoa1301372 · 2013 · External reference
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
10.1186/s12877-015-0029-9 · 2015 · External reference
Post-operative delirium in elderly patients: a narrative review
10.3390/ijms262311314 · 2025 · External reference
Clinical nursing management of adult patients with delirium in a Hospital Setting-A systematic review
10.3390/jcm14228113 · 2025 · External reference
A disproportionality analysis of adverse events associated with ertapenem using the FAERS database from 2004 to 2024
10.1038/s41598-025-02359-3 · 2025 · External reference
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome
10.1002/14651858.cd013540.pub2 · 2021 · External reference
Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study
10.1136/bmj.e420 · 2012 · External reference
Medication-induced causes of delirium in patients with and without dementia: a systematic review of published neurology guidelines
10.1007/s11096-024-01861-4 · 2025 · External reference
Delirium
10.1038/s41572-020-00223-4 · 2020 · External reference
Disproportionality analysis of amenamevir-induced encephalopathy using the Japanese adverse drug event report database
10.1016/j.jiac.2024.09.008 · 2025 · External reference
A hierarchical model for analyzing multisite individual-level disease surveillance data from multiple systems
10.1111/biom.13647 · 2023 · External reference
